Share Price and Basic Stock Data
Last Updated: June 9, 2025, 11:17 pm
| PEG Ratio | 0.25 |
|---|
Competitors of Genesis IBRC India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 15.8 Cr. | 51.9 | 108/39.5 | 44.0 | 12.7 | 0.00 % | 11.8 % | 9.68 % | 10.0 |
| Genesis IBRC India Ltd | 26.3 Cr. | 20.2 | 20.2/13.7 | 7.51 | 6.56 | 0.00 % | 51.6 % | 51.6 % | 10.0 |
| Shreeoswal Seeds & Chemicals Ltd | 129 Cr. | 14.1 | 40.8/11.6 | 36.4 | 4.78 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 400 Cr. | 210 | 264/138 | 9.60 | 341 | 0.94 % | 7.20 % | 6.61 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 27.0 Cr. | 24.5 | 70.2/22.1 | 45.7 | 25.8 | 0.00 % | 4.29 % | 2.87 % | 10.0 |
| Industry Average | 264.50 Cr | 64.14 | 28.64 | 78.17 | 0.19% | 16.95% | 15.83% | 8.40 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.67 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.05 | 0.01 | 0.02 | 0.05 | 0.06 | 0.02 | 0.02 | 3.69 | 0.10 | 0.02 | 0.03 | 0.02 |
| Operating Profit | -0.03 | -0.05 | -0.01 | -0.02 | -0.05 | -0.06 | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 |
| OPM % | 99.46% | ||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.03 | -0.05 | -0.01 | -0.02 | -0.05 | -0.06 | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.03 | -0.05 | -0.01 | -0.02 | -0.05 | -0.06 | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 |
| EPS in Rs | -0.02 | -0.04 | -0.01 | -0.02 | -0.04 | -0.05 | -0.02 | -0.02 | -2.84 | -0.08 | 2.81 | -0.02 | -0.02 |
Last Updated: May 31, 2025, 5:55 am
Below is a detailed analysis of the quarterly data for Genesis IBRC India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Expenses, as of Mar 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Dec 2024) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.03 Cr. (Dec 2024) to -0.02 Cr., marking an increase of 0.01 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -0.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.03 Cr. (Dec 2024) to -0.02 Cr., marking an increase of 0.01 Cr..
- For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Net Profit, as of Mar 2025, the value is -0.02 Cr.. The value appears strong and on an upward trend. It has increased from -0.03 Cr. (Dec 2024) to -0.02 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.02. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded -0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:14 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.39 | 0.78 | 0.00 | 0.00 | 0.29 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.55 | 0.93 | 0.07 | 0.07 | 0.49 | 0.10 | 0.10 | 0.12 | 0.12 | 0.14 | 3.80 | 0.17 |
| Operating Profit | -0.16 | -0.15 | -0.07 | -0.07 | -0.20 | -0.05 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | -0.17 |
| OPM % | -41.03% | -19.23% | -68.97% | -100.00% | ||||||||
| Other Income | 0.01 | -0.09 | 0.42 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.67 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.18 | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.33 | -0.45 | 0.35 | 0.00 | -0.20 | -0.05 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.50 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.33 | -0.44 | 0.35 | 0.00 | -0.20 | -0.05 | -0.10 | -0.12 | -0.12 | -0.14 | -3.80 | 3.50 |
| EPS in Rs | -1.09 | -0.62 | 0.36 | 0.00 | -0.15 | -0.04 | -0.08 | -0.09 | -0.09 | -0.11 | -2.92 | 2.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -33.33% | 179.55% | -100.00% | 75.00% | -100.00% | -20.00% | 0.00% | -16.67% | -2614.29% | 192.11% |
| Change in YoY Net Profit Growth (%) | 0.00% | 212.88% | -279.55% | 175.00% | -175.00% | 80.00% | 20.00% | -16.67% | -2597.62% | 2806.39% |
Genesis IBRC India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 106% |
| 3 Years: | 215% |
| TTM: | 192% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 22% |
| 3 Years: | 27% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -2% |
| 3 Years: | -2% |
| Last Year: | 52% |
Last Updated: Unknown
No data available for the Balance Sheet data table.
Cash Flow
| Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data available for the Financial Efficiency data table.
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | -0.03 |
| Diluted EPS (Rs.) | -0.03 |
| Cash EPS (Rs.) | 0.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 7.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 7.39 |
| Revenue From Operations / Share (Rs.) | 3.33 |
| PBDIT / Share (Rs.) | 0.14 |
| PBIT / Share (Rs.) | 0.06 |
| PBT / Share (Rs.) | 0.04 |
| Net Profit / Share (Rs.) | -0.02 |
| NP After MI And SOA / Share (Rs.) | -0.02 |
| PBDIT Margin (%) | 4.20 |
| PBIT Margin (%) | 2.02 |
| PBT Margin (%) | 1.41 |
| Net Profit Margin (%) | -0.78 |
| NP After MI And SOA Margin (%) | -0.78 |
| Return on Networth / Equity (%) | -0.35 |
| Return on Capital Employeed (%) | 0.87 |
| Return On Assets (%) | -0.27 |
| Current Ratio (X) | 3.24 |
| Quick Ratio (X) | 3.00 |
| Interest Coverage Ratio (X) | 6.83 |
| Interest Coverage Ratio (Post Tax) (X) | -0.27 |
| Enterprise Value (Cr.) | 6.58 |
| EV / Net Operating Revenue (X) | 1.52 |
| EV / EBITDA (X) | 36.12 |
| MarketCap / Net Operating Revenue (X) | 1.59 |
| Price / BV (X) | 0.71 |
| Price / Net Operating Revenue (X) | 1.59 |
After reviewing the key financial ratios for Genesis IBRC India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 18, the value is -0.03. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 18, the value is -0.03. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 18, the value is 0.04. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 7.39. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 7.39. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 3.33. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 0.14. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 18, the value is 0.06. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 18, the value is 0.04. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 18, the value is -0.02. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is -0.02. This value is below the healthy minimum of 2. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 18, the value is 4.20. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 18, the value is 2.02. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 18, the value is 1.41. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 18, the value is -0.78. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is -0.78. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 18, the value is -0.35. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 18, the value is 0.87. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 18, the value is -0.27. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 18, the value is 3.24. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 18, the value is 3.00. This value exceeds the healthy maximum of 2. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 6.83. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is -0.27. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 18, the value is 6.58. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 18, the value is 36.12. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.59. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 18, the value is 0.71. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.59. This value is within the healthy range. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Genesis IBRC India Ltd:
- Net Profit Margin: -0.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.87% (Industry Average ROCE: 16.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.35% (Industry Average ROE: 15.83%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.27
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.51 (Industry average Stock P/E: 28.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -0.78%
About the Company - Qualitative Analysis
Genesis IBRC India Ltd. is a Public Limited Listed company incorporated on 23/10/1992 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L47733AP1992PLC107068 and registration number is 107068. Currently Company is involved in the business activities of Manufacture of other animal feeds. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.00 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | Flat No.401, VVN Residency, 40-A, Ashok Nagar, Eluru Andhra Pradesh 534002 | csgenesisiil@gmail.com www.genesisiil.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mohammed Baba | Independent Director |
| Mr. Balakrishna Koppula | Whole Time Director |
| Mrs. Vanitha Nagulavari | Non Executive Director |
| Mr. Prasada Rao Kalluri | Independent Director |